DGS Diagnostics
DGS Diagnostics is a Polish medical device manufacturer that designs, produces, and services audiometry, tympanometry, ABR, otoacoustic emission, and balance-disorder instruments for audiologists, ENT clinics, and hospitals worldwide.
- Company typePrivate
- Founded2009
- HeadquartersKolbaskowo, Poland
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What DGS Diagnostics does
DGS Diagnostics Sp. z o.o. is a Polish-headquartered medical device manufacturer (Kołbaskowo / Rosówek) that designs, produces, and services the full spectrum of clinical instruments used in hearing and balance diagnostics. Its portfolio covers five core product categories: audiometry, tympanometry, auditory brainstem response (ABR) systems, otoacoustic emission (OAE) testers, and vestibular balance assessment and treatment chairs. End customers are audiologists, hearing specialists, ENT clinics, hospitals, and newborn screening programs; the chairs extend the clinical surface from diagnosis alone into balance-disorder treatment. The company was founded on March 6, 2009 as Diagnostics Polska Production (later LEDISO, then DGS Diagnostics from 2013) and operates as the diagnostics manufacturing arm of Danish holding Demant, supplying diagnostic instruments to seven brands within the parent group and distributing through a network that reaches 146 countries. Business model revenue comes from (i) hardware sales of diagnostic instruments and balance chairs, and (ii) recurring after-sales service and maintenance contracts over the equipment lifecycle, sold through a direct enterprise field-sales motion to healthcare providers globally. Pricing is quote-based with no public list pricing, consistent with B2B regulated medical device sales.
Operationally, DGS has scaled from a few operational areas at founding to more than 20 operational areas and approximately 500 employees by 2024, anchored since 2023 by a purpose-built production-warehouse-office complex in Rosówek featuring an Autostore automated warehouse and open-space offices. The company runs dedicated R&D (electronics, mechanical) and production teams, and absorbs adjacent capabilities such as the SMD team integrated in 2023. Management is led by Poland-based CEO Paweł Muklewicz (since 2016), with Demant group-level oversight from Diagnostics SVP Gitte Heede Hesel (since 2023) and President of Diagnostics Anne-Karen Hunt (since 2024). The company is private, does not disclose revenue, and operates as a non-listed subsidiary of Demant.
DGS Diagnostics firmographics
Firmographics- Name
- DGS Diagnostics
- Legal name
- DGS Diagnostics
- Website
- https://dgs-diagnostics.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DGS Diagnostics is a Polish medical device manufacturer that designs, produces, and services audiometry, tympanometry, ABR, otoacoustic emission, and balance-disorder instruments for audiologists, ENT clinics, and hospitals worldwide.
- Ownership category
- akta.pro rank
DGS Diagnostics industry classification
Industry- Product category
- Audiology and Balance Diagnostic Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Electronic and Precision Equipment Repair and Maintenance (81121)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Audiology & Hearing Diagnostic Centers (HLAFAKAH)
Keywords
Where DGS Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Kolbaskowo
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
DGS Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Medical Diagnostic Device Sales: Design, manufacture and sale of comprehensive hearing and balance diagnostic instruments including audiometry, tympanometry, ABR, and otoacoustic emission devices
- After-Sales Service and Maintenance: Servicing of diagnostic equipment throughout product lifecycle
- Balance Disorder Treatment Solutions: Specialized chairs for diagnosis and treatment of balance disorders
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
DGS Diagnostics product offering
Product offeringCore offering
DGS Diagnostics designs, manufactures, and services a comprehensive spectrum of medical diagnostic instruments for hearing and balance assessment, including audiometry, tympanometry, ABR (Auditory Brainstem Response), otoacoustic emissions devices, and specialized balance disorder chairs. The company supplies these instruments globally to healthcare providers through its parent Demant group's distribution network, serving audiologists, ENT clinics, hospitals, and hearing specialists across 146 countries.
Product overview
DGS Diagnostics is a world leader in hearing and balance disorder diagnostics, manufacturing a comprehensive spectrum of diagnostic instruments. The product portfolio centers on five core instrument categories: audiometry, tympanometry, ABR (Auditory Brainstem Response), otoacoustic emissions, and balance disorder chairs. These devices enable hearing diagnosis and hearing aid fitting globally, while the specialized chairs allow for both diagnosis and treatment of balance disorders. The company supports 7 brands within the Demant group with these diagnostic solutions distributed to over 140 countries worldwide.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Products reach 146 countries worldwide
- +1 more outcomes
Companies that use DGS Diagnostics
Customer profileSegments2 records
Ideal customer profiles1 record
DGS Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DGS Diagnostics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DemantflagshipDGS Diagnostics belongs to Danish holding Demant, operating in hearing healthcare for over 120 years with branches in over 30 countries. Demant conducts four types of manufacturing: hearing aids, hearing implants, diagnostics, and communication. DGS supports 7 brands within the Demant group with diagnostic instruments.
Scale indicators5 records
Recent moves12 records
Expansion highlights5 records
DGS Diagnostics competitors and assessment
Company assessmentDirect peers
- Inventis: Italian manufacturer of audiology and balance diagnostic equipment (audiometers, tympanometers, video head impulse test systems). Direct competitor in the European clinical audiology market.
- Otometrics: Demant-owned hearing and balance diagnostic instrument maker. Overlapping portfolio in audiometry and vestibular diagnostics; another internal Demant peer to DGS.
- Interacoustics: Also owned by Demant, Interacoustics manufactures audiometry, tympanometry, ABR, OAE, and balance assessment instruments — a near-mirror product line to DGS, making it the closest comparable peer (and internal sister division).
- MAICO Diagnostics: Manufactures screening and diagnostic devices for audiology (audiometry, tympanometry, OAE) with global distribution. Comparable product scope and customer base to DGS.
- Grason-Stadler (GSI): Specialist manufacturer of clinical audiometers, tympanometers, and OAE/ABR systems used in audiology and ENT practices. Directly competes with DGS in hearing diagnostics hardware.
Emerging players
- Starkey Hearing Technologies: US-based hearing aid manufacturer investing in diagnostics and fitting technology. Overlaps with DGS at the hearing aid fitting/diagnostics interface but primarily a hearing-aid brand rather than instrument maker.
Broad incumbents
- Natus Medical: Broader neurodiagnostic and hearing-screening device maker with overlap in ABR and OAE newborn screening products. Wider portfolio (EEG, sleep, NICU) but competes head-on in auditory diagnostics.
- Sonova: Swiss hearing healthcare giant (Phonak, Unitron) that also owns diagnostic instrument brands. Adjacent incumbent that competes for clinical audiology wallet share through integrated hearing-care solutions.
- GN Hearing: Hearing aids and audio solutions parent (ReSound, Jabra). Less direct overlap in diagnostic hardware, but a broad incumbent in the same end-customer category (audiology clinics and hearing care professionals).
Others
- Amplifon: Global hearing care retail and services operator. Not a diagnostic equipment maker, but an indirect customer/ecosystem participant — large-scale buyer of audiology diagnostic instruments and clinical services for its network.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
DGS Diagnostics social profiles
Digital presenceDGS Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
DGS Diagnostics leadership team
Management profileNumber of profiles
Profiles4 records
DGS Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DGS Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DGS Diagnostics
What does DGS Diagnostics do?
DGS Diagnostics designs, manufactures, and services a comprehensive spectrum of medical diagnostic instruments for hearing and balance assessment, including audiometry, tympanometry, ABR (Auditory Brainstem Response), otoacoustic emissions devices, and specialized balance disorder chairs. The company supplies these instruments globally to healthcare providers through its parent Demant group's distribution network, serving audiologists, ENT clinics, hospitals, and hearing specialists across 146 countries.
Is DGS Diagnostics a public or private company?
DGS Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was DGS Diagnostics founded?
DGS Diagnostics was founded in 2009. It employs 101 to 250 people.
Where is DGS Diagnostics based?
DGS Diagnostics is headquartered in Kolbaskowo, Poland, in the Europe region.
How does DGS Diagnostics make money?
Three revenue lines are on record. Medical Diagnostic Device Sales are the primary driver. The others are after-Sales Service and Maintenance and balance Disorder Treatment Solutions.
Who are DGS Diagnostics's main competitors?
Direct peers on record are Inventis, Otometrics, Interacoustics, MAICO Diagnostics and Grason-Stadler (GSI). Starkey Hearing Technologies is listed as an emerging player. Broad incumbents are Natus Medical, Sonova and GN Hearing. Amplifon is listed as an others.
Does DGS Diagnostics have an API?
No public API is recorded for DGS Diagnostics.
What industry is DGS Diagnostics in?
DGS Diagnostics's product category is Audiology and Balance Diagnostic Devices. Its primary akta.pro industry code is HLAFAKAH, Audiology & Hearing Diagnostic Centers. Its NAICS code is 339112 and its SIC code is 3841.